Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus
Vaccines · 26.10.2026 · 14 (11) · 930
DOI: 10.3390/vaccines14110930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.10.2026. Verfasst von Bin Wang und 5 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Scientific Research Program of the Shaanxi Provincial Department of Education, Internal Scientific Research Fund Project of Shaanxi A&F Technology University.
Abstract (Originalsprache)
Background
Caseous lymphadenitis (CLA) is a significant infectious disease in sheep and goats, traditionally associated with Corynebacterium pseudotuberculosis. However, recent evidence highlights the polymicrobial nature of CLA, with Trueperella pyogenes and Staphylococcus aureus frequently co-isolated from lesions. Current vaccines mainly target single pathogens, and combined inactivated vaccines against all three bacteria are lacking.
Methods
We developed a trivalent inactivated vaccine using strains CpS1, TpS1, and SaS9, inactivated with 0.2% formalin and formulated with either PBS, Freund’s adjuvant, or aluminum hydroxide adjuvant. Vaccine quality, safety, and immunogenicity were evaluated in experimental goats. The aluminum hydroxide-adjuvanted vaccine was further assessed for protective efficacy via challenge with individual pathogens and in field trials on goat and sheep farms.
Results
All formulations induced specific antibodies against the three pathogens, with Freund’s adjuvant eliciting the highest level, while aluminum hydroxide provided a favorable safety profile and induced antibody levels that were numerically lower than but not statistically distinguishable from the Freund’s adjuvant group at most time points; however, the small group size (n = 6) limited the statistical power to detect differences between adjuvants. The aluminum hydroxide-adjuvanted vaccine conferred protection rates of 66.7% against C. pseudotuberculosis, 83.3% against T. pyogenes, and 83.3% against S. aureus in challenge trials. In field studies, vaccination was associated with a lower observed incidence of CLA, from 12.5% in unvaccinated controls to 2.5% in vaccinated goats and from 8% to 2% in vaccinated sheep within 90 days post-immunization.
Conclusions
The trivalent inactivated vaccine with aluminum hydroxide adjuvant showed promising immunogenicity and preliminary protective efficacy against experimental challenge and was associated with a lower observed overall abscess incidence under the investigated field conditions.
Förderung
- Key Scientific Research Program of the Shaanxi Provincial Department of Education
- Internal Scientific Research Fund Project of Shaanxi A&F Technology University
Zitieren
APA
Wang, B., Wei, Y., Jia, Y., Bai, X., Qiu, X., & Yang, Z. (2026). Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus. Vaccines, 14(11), 930. https://doi.org/10.3390/vaccines14110930
Vancouver
Wang B, Wei Y, Jia Y, Bai X, Qiu X, Yang Z. Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus. Vaccines. 2026;14(11):930. doi:10.3390/vaccines14110930
BibTeX
@article{Wang2026,
author = {Wang, Bin and Wei, Yuchen and Jia, Yanqing and Bai, Xindong and Qiu, Xinxin and Yang, Zengqi},
title = {Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {11},
pages = {930},
doi = {10.3390/vaccines14110930}
}
EUVIMED